Designing quinoline-isoniazid hybrids as potent anti-tubercular agents inhibiting mycolic acid biosynthesis
Matthéo Alcaraz, Bharvi Sharma, Françoise Roquet‐Banères, Cyril Condé, Thierry Cochard, Franck Biet, Vipan Kumar, Laurent Kremer
Topics & Concepts
INHAIsoniazidMycobacterium tuberculosisMycolic acidChemistryBiosynthesisReductaseTuberculosisBiochemistryPharmacologyEnzymeBiologyMedicinePathologyTuberculosis Research and EpidemiologyPneumocystis jirovecii pneumonia detection and treatmentBiochemical and Molecular Research